Labor shortages at Teva Pharmaceuticals have made Adderall, a widely used attention-deficit/hyperactivity disorder (ADHD) drug, hard to find in some drugstores. But the U.S. Food and Drug Administration noted that there’s no overall shortage of ADHD medications. Only Teva is reporting supply problems, FDA spokeswomen Cherie Duvall-Jones told NBC News. “Teva Pharmaceuticals, the maker for Adderall...
Boosting levels of the neurotransmitter norepinephrine with atomoxetine, a repurposed ADHD medication, may be able to stall neurodegeneration in people with early signs of Alzheimer’s disease, according to a new study. The results appear in the journal Brain. This is one of the first published clinical studies to show a significant effect on the protein tau,...
by Linda A. Johnson This undated image provided by Supernus Pharmaceuticals in April 2021 shows bottles for different dosages of the drug Qelbree. On Friday, April 2, 2021, the U.S. Food and Drug Administration approved the medication for treating attention deficit hyperactivity disorder in children ages six through 17. (Supernus Pharmaceuticals via AP) U.S. regulators...
